77 Partners is an early-stage venture capital firm that backs ambitious Australian founders at the pre-seed and seed stages. The firm focuses on FrontierTech, including AI & Machine Learning, IoT & Edge Computing, Advanced Manufacturing & Robotics, Energy & Smart Infrastructure, Quantum & Cybersecurity.
About 77 Partners
77 Partners is a Brisbane, Australia-based pre-seed and seed VC focused on artificial intelligence, internet of things, and robotics. The fund’s geographic scope spans Australia and the United States. The source record flags the entity as not healthcare-relevant, with no disclosed healthcare sub-vertical exposure. For physician AI and digital health founders, this is not a healthcare investor.
The relevance for healthcare-tangent founders is narrow but plausible where AI, IoT, or robotics primitives have credible downstream applications in clinical environments, including surgical robotics, medical IoT, hospital operations automation, and physical sensors for clinical or remote-monitoring use cases. Founders should not assume the fund will lean into clinical regulatory or provider-commercialization work, however, and should confirm any healthcare-adjacent activity in the current book before investing pitch time. Portfolio companies are not disclosed in the input record.
Check size is not specified in the source record. Stages are pre-seed and seed, with Australia and US geographic scope. As a Brisbane-based fund, 77 Partners is one of the smaller Australian regional pre-seed players and is best modeled as a participation investor in syndicates rather than a sole lead on capital-intensive hardware rounds.
Named team members are not provided in the input record. The firm’s website and LinkedIn page are the right references for partner identification.
Approach 77 Partners only when you are an Australian or US founder building AI, IoT, or robotics technology with a credible non-healthcare core market and a possible clinical or medical-device downstream application, and you want a small Australian-based early check with a regional ecosystem network. Pure digital health, physician-facing software, EHR-adjacent tools, payer-direct US plays, and clinical workflow founders should redirect to healthcare-dedicated funds, where both the capital and the network are higher leverage. The right entry, if a fit exists, is a warm introduction from an Australian founder in the AI or robotics ecosystem, a Brisbane-area startup operator, or a fellow pre-seed fund. When pitching, lead with the technical primitive, the hardware or software stack, and the primary commercial market, because that maps to how a regional AI and robotics fund underwrites. Healthcare framing should be secondary at most.
Founder reviews
Other portfolio companies
Companies in 77 Partners's portfolio not currently in our directory.
- Lacroo Technologies
- Vinte
- Xillions AI
- Kurloo Technology
Team
Pitch / review this investor
Have you raised from 77 Partners? Founders only — share your honest experience (anonymous OK, moderated before publishing).